Capgemini SE (CAP) | Financial Analysis & Statements
Capgemini SE Large-cap Technology
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
29.1B
Total Liabilities
17.4B
Shareholders Equity
11.7B
Debt to Equity
1.49
Cash Flow Metrics
Revenue & Profitability Trend
Annual Income Flow
2025
Capgemini SE Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 22.5B | 22.1B | 22.5B | 22.0B | 18.2B |
| Cost of Goods Sold | 16.4B | 16.0B | 16.5B | 16.2B | 13.4B |
| Gross Profit | 6.1B | 6.1B | 6.0B | 5.8B | 4.8B |
| Gross Margin % | 27.0% | 27.4% | 26.9% | 26.5% | 26.4% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 3.1B | 3.1B | 3.1B | 3.0B | 2.5B |
| Other Operating Expenses | 116.0M | 46.0M | 49.0M | 36.0M | 194.0M |
| Total Operating Expenses | 3.2B | 3.2B | 3.1B | 3.0B | 2.6B |
| Operating Income | 2.5B | 2.5B | 2.6B | 2.6B | 2.1B |
| Operating Margin % | 11.1% | 11.5% | 11.5% | 11.6% | 11.3% |
| Non-Operating Items | |||||
| Interest Income | 156.0M | 207.0M | 171.0M | 65.0M | 24.0M |
| Interest Expense | 198.0M | 183.0M | 186.0M | 157.0M | 178.0M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 2.2B | 2.4B | 2.3B | 2.3B | 1.7B |
| Income Tax | 534.0M | 681.0M | 626.0M | 710.0M | 526.0M |
| Effective Tax Rate % | 24.6% | 28.7% | 27.2% | 31.4% | 31.3% |
| Net Income | 1.6B | 1.7B | 1.7B | 1.6B | 1.2B |
| Net Margin % | 7.2% | 7.6% | 7.4% | 7.0% | 6.4% |
| Key Metrics | |||||
| EBITDA | 3.3B | 3.4B | 3.4B | 3.3B | 2.7B |
| EPS (Basic) | €9.46 | €9.82 | €9.70 | €9.09 | €6.87 |
| EPS (Diluted) | €9.13 | €9.47 | €9.37 | €8.79 | €6.66 |
| Basic Shares Outstanding | 169347632 | 170201409 | 171350138 | 170251066 | 168574058 |
| Diluted Shares Outstanding | 169347632 | 170201409 | 171350138 | 170251066 | 168574058 |
Income Statement Trend
Capgemini SE Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 2.8B | 2.8B | 3.5B | 3.8B | 3.1B |
| Short-term Investments | 218.0M | 268.0M | 161.0M | 386.0M | 385.0M |
| Accounts Receivable | 3.3B | 3.2B | 3.3B | 3.3B | 3.1B |
| Inventory | - | - | - | - | - |
| Other Current Assets | 34.0M | 63.0M | 61.0M | 76.0M | 67.0M |
| Total Current Assets | 9.5B | 9.3B | 9.7B | 10.3B | 9.0B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 2.2B | 2.1B | 2.0B | 1.8B | 1.7B |
| Goodwill | 30.8B | 25.5B | 23.2B | 23.1B | 22.3B |
| Intangible Assets | 1.1B | 837.0M | 798.0M | 906.0M | 1.0B |
| Long-term Investments | 43.0M | 67.0M | 73.0M | 65.0M | 75.0M |
| Other Non-Current Assets | 32.0M | 42.0M | 32.0M | 35.0M | 54.0M |
| Total Non-Current Assets | 19.6B | 16.4B | 15.0B | 15.1B | 15.0B |
| Total Assets | 29.1B | 25.7B | 24.7B | 25.5B | 24.0B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 1.5B | 1.6B | 1.5B | 1.7B | 1.6B |
| Short-term Debt | 1.2B | 1.1B | 926.0M | 1.4B | 361.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 322.0M | 237.0M | 182.0M | 316.0M | 175.0M |
| Total Current Liabilities | 7.9B | 7.7B | 7.2B | 8.1B | 6.5B |
| Non-Current Liabilities | |||||
| Long-term Debt | 8.3B | 5.0B | 5.7B | 6.2B | 7.3B |
| Deferred Tax Liabilities | 292.0M | 267.0M | 275.0M | 308.0M | 294.0M |
| Other Non-Current Liabilities | 343.0M | 352.0M | 376.0M | 471.0M | 466.0M |
| Total Non-Current Liabilities | 9.5B | 6.2B | 7.0B | 7.7B | 9.0B |
| Total Liabilities | 17.4B | 13.9B | 14.2B | 15.7B | 15.6B |
| Equity | |||||
| Common Stock | 1.4B | 1.4B | 1.4B | 1.4B | 1.4B |
| Retained Earnings | 7.3B | 7.2B | 5.6B | 4.6B | 3.5B |
| Treasury Stock | - | - | 237.0M | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 11.7B | 11.8B | 10.5B | 9.7B | 8.5B |
| Key Metrics | |||||
| Total Debt | 9.5B | 6.1B | 6.6B | 7.5B | 7.6B |
| Working Capital | 1.6B | 1.6B | 2.5B | 2.3B | 2.5B |
Balance Sheet Composition
Capgemini SE Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 1.6B | 1.7B | 1.7B | 1.6B | 1.2B |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | 266.0M | 273.0M | 252.0M | 164.0M | 125.0M |
| Working Capital Changes | -150.0M | -263.0M | -152.0M | -308.0M | 178.0M |
| Operating Cash Flow | 1.7B | 1.6B | 1.8B | 1.5B | 1.6B |
| Investing Activities | |||||
| Capital Expenditures | -222.0M | -310.0M | -254.0M | -283.0M | -262.0M |
| Acquisitions | -3.8B | -827.0M | -343.0M | -204.0M | -369.0M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -4.0B | -1.3B | -383.0M | -659.0M | -678.0M |
| Financing Activities | |||||
| Share Repurchases | -543.0M | -989.0M | -876.0M | -826.0M | -197.0M |
| Dividends Paid | -581.0M | -584.0M | -559.0M | -409.0M | -329.0M |
| Debt Issuance | 7.3B | 847.0M | 1.9B | 468.0M | 137.0M |
| Debt Repayment | -4.3B | -1.4B | -2.9B | -482.0M | -1.8B |
| Financing Cash Flow | 2.3B | -1.6B | -1.8B | -677.0M | -2.2B |
| Free Cash Flow | 2.2B | 2.2B | 2.3B | 2.2B | 2.3B |
| Net Change in Cash | -19.0M | -1.3B | -458.0M | 137.0M | -1.3B |
Cash Flow Trend
Capgemini SE Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
10.85
Forward P/E
7.17
Price to Book
1.44
Price to Sales
0.74
PEG Ratio
7.17
Profitability Ratios
Profit Margin
7.13%
Operating Margin
11.97%
Return on Equity
13.70%
Return on Assets
5.72%
Financial Health
Current Ratio
1.21
Debt to Equity
81.03
Beta
0.65
Per Share Data
EPS (TTM)
€9.13
Book Value per Share
€68.62
Revenue per Share
€132.66
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| CAP | 16.6B | 10.85 | 1.44 | 13.70% | 7.13% | 81.03 |
| Sopra Steria | 2.3B | 7.97 | 1.12 | 14.72% | 5.26% | 55.22 |
| Alten S.A | 2.0B | 13.80 | 0.94 | 4.82% | 2.61% | 13.02 |
| Wavestone S.A | 1.1B | 14.11 | 1.73 | 12.91% | 8.33% | 6.28 |
| Neurones S.A | 891.4M | 17.76 | 2.49 | 12.05% | 6.08% | 0.10 |
Financial data is updated regularly. All figures are in the company's reporting currency.